KALA BIO, Inc.
KALA
Ранг среди акций
#30748
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Цена акции
$0.75
Последняя синхронизация: 2026-07-31
Рыночная капитализация
$14.50M
Изменение (1 день)
2.78%
Изменение (1 год)
-98.28%
Страна
US
Торговля KALA BIO, Inc. (KALA)
Категория
Healthcare
История цены акций KALA BIO, Inc. (KALA)
Наивысшая цена закрытия: $0.28 2026-10-01
Наименьшая цена закрытия: $37.46K 2018-01-01
Наименьшая цена закрытия: $37.46K 2018-01-01
История цены акций KALA BIO, Inc. с 2018 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2026 (TTM) | -64.03% |
| 2025 | -88.09% |
| 2024 | -12.41% |
| 2023 | -37.21% |
| 2022 | -84.21% |
| 2021 | -79.90% |
| 2020 | 49.13% |
| 2019 | 15.30% |
| 2018 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $533.96 | 25.21% |
US
|
|
| $232.80 | 767.04% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $882.27 | 8.36% |
NL
|
|
| $290.30 | 1.99% |
BE
|
